1.. Introduction
================

Restless legs syndrome (RLS) or Willis-Ekbom is a chronic motor-sensory disorder characterized with intense desire to shake the legs during sleep ([@B1]). The desire to shake the legs causes unpleasant feeling, which is described as high heartbeat, irritation or tingling, or as if insects are crawling on the legs. The symptoms are intensified when the patients are not physically active ([@B2]; [@B3]). The international restless legs syndrome study group (IRLSSG) introduced 4 criteria to diagnose the syndrome; unpleasant sense of restless legs, desire to keep shaking the legs, aggravation of the symptoms at night and in the evening, and alleviation of the symptoms by shaking the legs ([@B4]).

RLS is one of the most prevalent sleep disorders, which is not diagnosed in most the cases or the symptoms may lead to wrong diagnosis ([@B5]). As suggested by the reports, out of 80% of RLS patients who seek medical attention, only 25% of the cases are properly diagnosed, and in turn only 13% receive effective medications ([@B6]). The syndrome is observed as idiopathic or secondary problem of other diseases such as rheumatology, diabetes, MS, neurological diseases, and renal problems (patients under dialysis in particular) ([@B7]). The main causes of RLS are unknown; however, low serum iron and ferritin, changes in hormonal level of calcium, phosphate, and parathyroid and its consequences on nervous system are claimed responsible in development of the symptoms ([@B8]).

Prevalence of RLS is 2% to 20% ([@B3]; [@B9]) and studies have shown that it is considerably higher among patients undergoing hemo-dialysis (up to 60%) ([@B10]; [@B11]). In addition to the unpleasant sense of restlessness of the legs, the syndrome is the root of other disorders such as depression, sleep deprivation, fatigue during the day, driving problems, problems in doing daily tasks, excessive daytime sleepiness, stress, and anxiety ([@B6]; [@B12]; [@B13]; [@B14]).

Moreover, the syndrome may cause problems in the dialysis process ([@B9]). Development of RLS among patients in need of dialysis tackles quality of life and the patient's adaptation to dialysis; and along with psychological disorders, it causes serious issues such as cardiovascular diseases and increase of risk of death ([@B15]). Knowing that programming and taking steps to prevent and treat the RLS needs accurate statistics about prevalence of RLS among patients under hemodialysis, the present study aimed to estimate the prevalence of the disease among patients undergoing hemodialysis.

2.. Methods
===========

This systematic review and meta-analysis study was carried out to measure prevalence of RLS syndrome among patients undergoing hemodialysis by reviewing articles indexed in international and Iranian journals. To this end, articles on the prevalence of RLS were searched in Iranian and international databases such as SID, MagIran, Google Scholar, IranMedex, ScienceDirect, PubMed, PreQuest, and Scopus. The keywords used in the search were "restless legs syndrome," "symptoms of restless legs syndrome," "hemodialysis," combinations of these terms, and Farsi equivalents of the terms in case of articles published in Farsi. To extend the scope of the search, references of the articles found in primary search were also reviewed.

2.1.. Inclusion criteria and data extraction
--------------------------------------------

At first, all articles about the prevalence of RLS among patients undergoing hemodialysis were collected and irrelevant articles were removed based on exclusion criteria, including irrelevancy, medical interventions on the subjects, duplicate articles, and unavailability of the full text. In addition, studies on a combination of the hemodialysis and peritoneal dialysis or only peritoneal patients were excluded. Taking into account the inclusion and exclusion criteria, summary of the articles were examined by two independent researchers (RGG and MF) and a third researcher (expert in meta-analysis) settled any cases of disagreements. Totally, 26 articles published between 2001 and 2015 were selected based on inclusion and exclusion criteria.

2.2.. Statistical analysis
--------------------------

Given that prevalence is a binomial distribution, variance of prevalence was calculated through binomial distribution variance. To combine prevalence data from different articles, weighted average was obtained so that weight of each article was inverse of the variance. To survey heterogeneity of the data, I2 index was utilized. Heterogeneity was categorized in 3 groups of low heterogeneity (25%), average heterogeneity (25%--75%), and high heterogeneity (\>75%). Taking into account heterogeneity of the data (94.6%), random effects model was used. The relationship among prevalence of the syndrome, the number of subjects and year of publication was examined by meta-regression. Data analyses were carried out in STATA (11.2).

3.. Results
===========

All English articles published between 2000 and 2015 on RLS among hemodialysis entered the systematic review and meta-analysis process based on PRISMA instruction ([@B16]). Totally, 55 articles were selected through primary search and based on inclusion and exclusion criteria, 29 articles entered final analysis stage. The selection flow chart is pictured in [Figure 1](#F1){ref-type="fig"}.
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The articles entered the final review stage were those published from 2001 to 2014 and represented the total number of 6188 subjects (238 participants per study). The smallest sample group was in [@B39]) ([@B17]) study with 41 participants and the largest sample group was in Merlino et al. ([@B18]) study, with 883 participants. Highest and lowest prevalence rates of RLS were (68%) reported by Cotner et al. ([@B19]) in the USA and (7%) by Biomik et al. in India ([@B20]). Fifteen articles (57.6%) were done in Asia; for further details of the articles see [Table 1](#T1){ref-type="table"}.

###### 

Specifications of the articles in systematic review and meta-analysis of prevalence of RLS among patients undergoing hemodialysis.

  **Authors**             **Year**   **N**   **Prevalence**   **95% CI**   **Country**   **Male (%)**   
  ----------------------- ---------- ------- ---------------- ------------ ------------- -------------- ------
  Higuchi et al.          2015       159     22               16           22            Japan          71
  Wali et al.             2015       355     19               15           24            Saudi Arabia   91
  Bidaki et al.           2014       160     67               60           74            Iran           51.1
  Haider et al.           2014       250     65               59           71            Pakistan       61.2
  Sharifi et al.          2013       80      57               47           68            Iran           51.2
  Stefanidis et al.       2013       579     27               23           30            Greece         59.2
  Hemati et al.           2012       171     57               50           65            Iran           55.6
  Habibzadeh et al.       2012       168     39               31           46            Iran           48.2
  Salman et al.           2011       123     20               13           27            Syria          56.9
  Araujo et al.           2010       400     22               17           26            Brazil         59
  Soyoral et al.          2010       76      14               7            22            Turkey         55.2
  La Manna et al.         2010       100     31               22           40            Italy          63
  Shahidi et al.          2010       41      17               6            29            Iran           51.2
  Al-Jahdali et al.       2009       227     50               44           57            Saudi Arabia   53.7
  Salimpour et al.        2009       130     33               25           41            Iran           63.1
  Kim et al.              2008       164     28               21           35            Korea          56
  Merlino et al.          2006       883     27               24           30            Italy          \-
  Mucsi et al.            2005       333     14               10           18            Hungary        58
  Molahosseini et al.     2005       514     62               57           66            Iran           73.4
  Mucsi et al.            2004       78      32               22           42            Hungary        \-
  Bhowmik et al.          2003       121     7                2            11            India          84.2
  Takaki et al.           2003       426     16               13           20            Japan          60
  Goffredo Filho et al.   2003       176     15               10           20            Brazil         60.8
  Kutner et al.           2002       183     48               41           55            USA            51.9
  Kutner et al.           2002       125     68               60           76            USA            45.6
  Miranda et al.          2001       166     26               19           33            Chile          \-

Given the high level of heterogeneity (97.6%) among the articles under study, random effects model was used. The model assumes that the differences between the results are due to differences in sampling process and the obtained scores by the subjects. Estimate of RLS prevalence among patients undergoing hemodialysis based on the random effects model was 34% for 6188 participants (95% CI: 27--41). The articles were categorized based on which continent the study was conducted ([Figures 2](#F2){ref-type="fig"} and [3](#F3){ref-type="fig"}).
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Meta-regression diagrams ([Figures 4](#F4){ref-type="fig"} and [5](#F5){ref-type="fig"}) indicate no relationship between prevalence of RLS in patients undergoing hemodialysis and year of article publication (P=0.419), and between prevalence of RLS in these patients and their ages (0.604). That is, the prevalence of RLS among patients undergoing hemodialysis does not change significantly based on their ages or year of article publication.
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4.. Discussion
==============

Results of different studies on the prevalence of RLS in patients undergoing hemodialysis were examined and general prevalence of the syndrome among them was obtained as 34% (95% CI: 27--41). Prevalence of RLS in the patients undergoing hemodialysis was higher than that of healthy population; however, this is inconsistent with studies on hemodialysis and peritoneal dialysis patients. [@B12] reported the prevalence of RLS in patients undergoing hemodialysis as 35.5% and patients under peritoneal dialysis as 17.7% ([@B36]). Al-Jahdali maintained that the prevalence of RLS among patients under hemodialysis (69%) was higher than that of patients under peritoneal dialysis (46%) ([@B38]). Decrease of renal function increases risk of RLS and only after kidney transplant, the risk of RLS returns to average level of normal population ([@B39]). Studies have also shown that in patients with renal failure, symptoms of RLS syndrome may improve after kidney transplant and no considerable improvement is expected after dialysis ([@B40]). Although, the pathophysiological relationship between development of RLS syndrome and renal failure is vague, it appears that lack of vitamins, iron deficiency, and anemia are the key factors to blame.

RLS syndrome in hemodialysis patients leads to low life quality, high immunology and cardiovascular diseases, high blood pressure, sleep deprivation, daytime sleepiness, fatigue, daytime functions disorders. Anera notes that mortality risk of RLS hemodialysis patients is 1.4 times higher than that of the patients without RLS. In general, the hardships of hemodialysis process and the consequences in the form of decrease of performance, social seclusion, lack of physical activities, and decrease of self-confidence on one hand and the problems rooted in RLS syndrome on the other hand not only tackle quality of life of the patients but also problematize routine life order of the family members.

Prevalence of RLS in patients undergoing hemodialysis reported by articles found in the Iranian databases (50%; CI: 38--61) was higher than that by articles found in the international databases (30%; CI: 23--37). The difference between the reported figures might be due to racial, cultural, socioeconomic status, and medical services differences.

The results also showed that studies in Asia and America reported higher RLS prevalence compared to European studies. Although, the syndrome can be developed in all races, many authors believe that it is more prevalent in white races ([@B42]). By referring to epidemiological studies, [@B6] stated that prevalence of RLS among European population was 5%--15% and this range for the North American population was 7.2%--11% ([@B43]). Prevalence of the syndrome among African Americans and white Americans with renal failure was 48% and 68%, respectively ([@B40]). Racial differences, probability of developing the disease, environmental factors (geographical position), and methodological limitations (e.g. small sample group, contradictory interpretation of the measures) all may lead to different results regarding the prevalence of RLS.

Based on the meta-regression results, prevalence of RLS does not correlate significantly with age of the subjects. Inconsistently however, studies have shown that prevalence of the syndrome increases up to age 79 and afterward it follows a descending trend ([@B41]). Given age distribution of the subjects, average age of the subjects in each study is not a reliable index to measure relationship between the patients and prevalence of RLS. In this regard, individual patients' data is a more reliable measure. Mucsi (2005) showed that age distribution of the patients with RLS and patients without RLS was not different ([@B30]). Regarding the relationship between the effects of age and race, [@B26] mentioned that high prevalence of RLS among European senior citizen population compared to African races, highlights the role of racial differences in this regard ([@B44]). Unavailability of full-text of some of the articles was one of the main limitations of the present study.

RLS causes sleep disorder, sleepiness, and sleep deprivation in patients undergoing hemodialysis and leads to cardiovascular and immunological problems. Because, RLS symptoms might not be recognized as a clinical problem, it usually remains undiagnosed in hemodialysis patients.

In general, it can be concluded that prevalence of RLS is higher among patients undergoing hemodialysis compared to general population and prevalence of the syndrome has not changed over the recent years. By diagnosing the hemodialysis patients with RLS, the unpleasant symptoms and problems caused by the symptoms can be alleviated.
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